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Introduction 
One of the stated goals of the Medicare Prescription Drug, Improvement and Modernization Act of 
2003 (MMA) was to reduce the burden that the cost of prescription drugs was placing on senior 
citizens. Prescription drugs were a large and rapidly growing share of expenditures for older 
households. Since most drugs were not covered under Medicare, seniors who were above the 
income thresholds for Medicaid were forced to bear most of the burden for prescription drugs 
themselves.  
 
The centerpiece of the 2003 MMA was the creation of a Medicare prescription drug benefit that 
would partially cover the cost of prescription drugs for seniors above the income threshold for 
Medicaid. The benefit also provided far more substantial subsidies for moderate-income seniors 
whose income still placed them above the Medicaid thresholds.  
 
This paper examines the extent to which the Medicare drug benefit reduced the burden of health 
care costs for seniors in 2006, the first year in which it was in effect. It uses data from the Bureau of 
Labor Statistics Consumer Expenditure Survey (CEX) to compare the change in health care 
spending by older households from 2004 to 2006. 
 
Spending on Prescription Drugs and Insurance by Older 
Households  
While the goal of the Medicare prescription drug benefit was to reduce the burden that prescription 
drug spending placed on older households, there is no easy way to get a direct measure of this 
burden. Many seniors did pay directly for drug purchases out of pocket, however, most had at least 
partial coverage, either through insurance provided by former employers or supplemental insurance 
they purchased themselves. As a result, direct spending on prescription drugs would only be a 
portion of what these households actually paid for their drugs. 
 
In order to get around this problem, our analysis combines spending on insurance with prescription 
drug spending. This has the advantage of making spending on prescription drugs effectively take the 
form of insurance premiums. However, it also makes the measure more imprecise.  
 
The Congressional Budget Office estimated that average spending on prescription drugs not 
covered by Medicare was $2,439 per Medicare beneficiary in 2003. Assuming an 8.4 percent increase 
for 2004, uncovered spending would have been about $2,640.1 This spending includes payments 
from all non-Medicare sources, including Medicaid and other state programs, employer-based 
insurance, and the Veterans Administration. Sources other than out-of-pocket spending or 
individually purchased policies accounted for 57 percent of non-Medicare purchases (CBO 2002, 
Figure 2), which implies that out-of-pocket spending or spending by individually purchased 
insurance policies would be equal to approximately $1,140 in 2004.    
 
                                                 
1 Congressional Budget Office, 2002. “Issues in Designing a Medicare Drug Benefit,” Washington, DC: Congressional 
Budget Office, available at http://www.cbo.gov/ftpdocs/39xx/doc3960/10-30-PrescriptionDrug.pdf, Table 1. The 
8.4 percent figure is taken from the Centers for Medicare and Medicaid Services, National Health Expenditures by 
Source of Funds and Type of Expenditure, 2001-2006 (Table 4) available at 
   http://www.cms.hhs.gov/NationalHealthExpendData/downloads/tables.pdf. 
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By comparison, the CEX shows average spending of $2,884 for the combination of health insurance 
premiums and out-of-pocket drug spending for households in which all members were over age 65. 
Since the average household with an individual over age 65 had 1.7 members, this implies average 
expenditures of $1,696 per household.2 (These adjustments are shown in Table 1.)  
 
TABLE 1 
Per Capita Household Spending on Prescription Drugs for 2004, CBO Projections and CEX Estimates 
 CBO CEX 
Base Number/Year  $2,439/2003 $2,884/2004 
Adjustment for Year (8.4%)       $2,640  -- 
Payment by Beneficiary (43%)   $1,140  -- 
Adjustment for Household Size (1.7)       --  $1,696 
Adjusted Spending $1,140  $1,696 
Source: CEX, CBO, see text.3 
 
Clearly this measure from the CEX includes substantial health care related expenditures that are not 
attributable to prescription drug spending, but the bulk of the spending captured by the CEX is 
presumably due to prescription drugs. This reduces the accuracy of the CEX data as a measure of 
household drug expenditures, but since roughly two-thirds of the spending in this combined 
insurance and drug expenditure category is likely directly or indirectly attributable to prescription 
drug expenditures, it should capture any large changes in spending. 
 
Table 2 shows average drug and insurance expenditures for households with all adults over age 65 
for the years 2004-2006, as well as spending by income quintile.  
 
TABLE 2 
Insurance and Drug Expenditures for Households with All Adults Over Age 65, 2004-2006 
 Mean 1st 2nd 3rd 4th 5th 
2004       
Income $29,181 $7,710 $13,631 $20,591 $32,303 $75,461 
Drug & Ins. Exp. $2,884 $1,795 $2,347 $2,910 $3,550 $3,945 
Percent of Income 9.9% 23.3% 17.2% 14.1% 11.0% 5.2% 
 (0.0027) (0.0068) (0.0032) (0.0028) (0.0023) (0.0023) 
2005       
Income $30,857 $7,735 $14,713 $21,881 $33,292 $80,669 
Drug & Ins. Exp. $3,084 $1,719 $2,439 $3,100 $3,835 $4,470 
Increase 2004-05 6.9% -4.2% 3.8% 6.5% 8.0% 13.3% 
Percent of Income 10.0% 22.2% 16.6% 14.2% 11.5% 5.5% 
 (0.0018) (0.0085) (0.0031) (0.0029) (0.0022) (0.0018) 
2006       
Income $32,272 $7,718 $14,836 $22,042 $34,055 $84,365 
Drug & Ins. Exp.          $3,331 $1,550 $2,504 $3,583 $4,357 $4,738 
Increase 2005-06 8.0% -9.8% 2.7% 15.6% 13.6% 6.0% 
Percent of Income  10.3% 20.1% 16.9% 16.3% 12.8% 5.6% 
 
(0.0028) (0.0070) (0.0029) (0.0038) (0.0026) (0.0022) 
Source: Authors’ calculations, see appendix. (Standard errors in parentheses.) 
 
The data provide some evidence of a reduction in the burden of drug expenditures in the bottom 
two quintiles, but no apparent effect for higher income households. Households in the two lowest 
                                                 
2  Data on the number of people per consuming unit in the CEX is available at the Bureau of Labor Statistics’ summary 
tables for the CEX, available at  ftp://ftp.bls.gov/pub/special.requests/ce/standard/2006/sage.txt. 
3  The CBO projections and the CEX estimates also differ due to the fact that roughly 20 percent of Medicare 
beneficiaries are disabled and not over age 65. Also, many people over age 65 live in households with adults under age 
65.  
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quintiles would most likely qualify for the supplemental drug benefit, which would give them 
substantial savings on prescription drugs, if they had not previously been eligible for Medicaid. It is 
therefore reasonable to expect that drug-related expenditures would decline or at least increase at a 
less rapid pace. 
 
Between 2005 and 2006, drug and insurance expenditures fell by 9.8 percent for the lowest quintile 
of elderly households. Expenditures rose by 2.7 percent for the households in the second quintile. 
This was lower than the 3.8 percent increase in spending in 2005, and far below the 8.0 percent 
average increase in spending for senior households between 2005 and 2006. This slower rate of 
growth may be seen as providing limited evidence of the benefits of the prescription drug benefit. 
 
However, it striking that households in the third and fourth quintiles actually experienced a more 
rapid increase in drug and insurance expenditures between 2005 and 2006 than in the prior year, or 
for the population as a whole. (Nationwide spending on prescription drugs rose by 8.5 percent from 
2005 to 2006.4)  
 
There are several factors that could explain this pattern. First, many seniors were slow to get into the 
new program. The enrollment deadline was not until May and many seniors did not enroll until well 
into this enrollment period. As a result, they would not have received the benefit of the Medicare 
subsidy for much of the year. Also, given the structure of the benefit, under which many plans had a 
substantial deductible, beneficiaries are likely to have a smaller share of their expenses fall above an 
annual deductible for a plan held less than a year.  
 
A second reason that higher-income beneficiaries may not have reduced their drug related 
expenditures is that many of them would have only received a subsidy through the program 
indirectly. The households in the 3rd and 4th quintiles are far more likely to have either employer-
provided insurance in retirement or have purchased supplemental Medicare insurance than the 
households in the lowest two quintiles. While both employer-provided plans and insurance plans 
that supplement Medicare are entitled to the subsidy provided under the MMA, households may not 
see much benefit.  
 
In the case of employer-provided insurance, the subsidies will lesson the burden on the former 
employer. The prospect of paying less for retiree coverage may give current workers some 
opportunity to get higher wages, but it is unlikely to be passed on to current retirees.  
 
In the case of supplemental Medicare plans, the extent to which they pass on the subsidy provided 
through the MMA will depend on the conditions of competition in the market. It is reasonable to 
believe that over time, competition is likely to push down the prices of these plans (more likely, slow 
the rate of increase) so that most of the subsidy will be passed on to beneficiaries. However, in the 
first year of the program’s operation, it would be reasonable to expect that most of the subsidy 
would go to higher profits for these insurers. If that is the case, then the increase in expenditures for 
beneficiaries with supplemental insurance plans is likely to be lower than for other beneficiaries in 
the near future.   
 
The third reason why expenditures might have increased more for households in the 3rd and 4th 
quintiles than for other beneficiaries is simply that they may now be taking more drugs. It is likely 
that many beneficiaries in these income groups restrained their drug consumption in prior years as a 
                                                 
4 Centers for Medicare and Medicaid Services, National Health Expenditures by Source of Funds and Type of   
Expenditure, 2001-2006 (Table 4) available at 
    http://www.cms.hhs.gov/NationalHealthExpendData/downloads/tables.pdf. 
The Impact of the Medicare Drug Benefit on Health Care Spending by Older Households   4 
result of being unable to afford high-priced medicines. The subsidies provided under the MMA 
suddenly made some drugs affordable that previously had not been. In this case, the increased 
expenditure for drugs and related health care expenses could be a positive development since it 
means that these households are now getting better health care and will presumably enjoy better 
health. Nonetheless, this does mean that the burden of health care expenses has increased for this 
group of elderly households. 
 
Conclusion 
A stated goal of the MMA was to reduce the financial burden that prescription drugs presented to 
seniors. While there is some evidence that it accomplished this goal for the least well-off seniors, this 
does not appear to be the case with seniors in the middle and upper income quintiles. In fact, the 
data suggest that drug related expenditures actually posed a larger burden to seniors in 2006, the first 
year the benefit was in place, than they had in prior years.  
 
As more years of data become available, it will be easier to determine the extent to which various 
groups of seniors may have benefited as a result of the MMA. However, this examination of data 
from the CEX indicates that only lower income seniors were able to reduce their health care 
spending as a result of the bill, even if higher income seniors may have enjoyed the benefit of 
increased access to drugs.      
 
Appendix 
Elderly expenditures on insurance and drugs are the authors’ analysis of the 2004-2006 Bureau of 
Labor Statistics Consumer Expenditure Survey (CEX). Our calculations use the Interview Panel of 
the CEX, a quarterly survey which re-interviews households to obtain one year of household 
expenditure data. 
 
We include all observations, using the BLS-imputed total before-tax income variable. Expenditures 
are prescription drug expenditures plus health insurance payments and fees. Our definition of a 
elderly household in the CEX is a consumer unit all of whose members are age 65 or older.  
 
To construct calendar year estimates from the rotating panel of the Interview Survey, we weight 
incomes and expenditures as described in the Bureau of Labor Statistics (BLS) 2006 Consumer 
Expenditure Interview Survey Public Use Microdata Documentation.5 We do not incorporate these 
weights when delineating income quintiles (although we use weights for estimates within each 
quintile). 
 
We calculate expenditure variance with the BLS-provided balanced repeated replication weights.6 
Since income means are based on multiply imputed data, the income variance accounts for both 
within- and between-imputation variance using the procedures outlined in the 2006 BLS User's 
Guide to Income Imputation in the CE.7  
                                                 
5 http://www.bls.gov/cex/2006/csxintvw.pdf 
6 ibid. 
7 http://www.bls.gov/cex/csxguide.pdf 
